The South Africa neurology devices market size is anticipated to register a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growth in the prevalence of neural disorders.
Neurological devices are medical devices that aid in the diagnosis, prevention, and treatment of a wide range of neurological diseases and situations, including Alzheimer's disease, major depression, Parkinson's disease, and traumatic brain injury.
To comprehend and assess patient problems, neurologists use a variety of equipment. Penlights, reflex hammers, eye charts, inclinometers, tuning forks, and neurological gadgets are among the neurology items available at QuickMedical.
The report on the South Africa neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Neurology Devices Market – South Africa Country Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Types of Devices (Interventional Neurology Devices [Neurothrombectomy Devices, Interventional/Surgical Simulators, Carotid Artery Stents, and Others], and Cerebrospinal Fluid Management Devices), Neurosurgery Devices (Stereotactic Systems, Neuroendoscopes, and Others), and Neurostimulation Devices (Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, and Others) |
Country |
South Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Integra LifeSciences Corporation; Smith & Nephew; Nihon Kohden Corporation; Johnson and Johnson; Abbott Laboratories; Medtronic PLC; Stryker Corporation; and Braun Melsungen AG |
Based on types of devices, the South Africa neurology devices market is segregated into interventional neurology devices [neurothrombectomy devices, interventional/surgical simulators, carotid artery stents, and others], and cerebrospinal fluid management devices. The cerebrospinal fluid management devices segment is expected to account for a key share of the market in the coming years owing to the increase in the use of this equipment for neurological device diagnostics. These monitoring devices, for example, are typically used to diagnose and cure multiple sclerosis, encephalitis, myelitis, and other diseases.
On the basis of neurosurgery devices, the market is segmented into stereotactic systems, neuroendoscopes, and others. The neuroendoscopes segment is expected to constitute a key share of the market during the forecast period owing to the neuroendoscopic surgery because it often causes the least amount of harm to normal structures, has a reduced rate of problems and produces great results. Surgeons can execute sophisticated operations through very tiny incisions using an endoscope and similar devices, which is highly helpful for minimally invasive surgical procedures for the spine. In both the lumbar and thoracic regions, endoscopic discectomy is becoming more prevalent.
In terms of neurostimulation devices, the South Africa neurology devices market is divided into sacral nerve stimulation devices, spinal cord stimulation devices, deep brain stimulation devices, and Others. The sacral nerve stimulation devices segment is expected to represent a key share of the market in the coming years due to the sacral nerve stimulation devices are typically utilized for individuals who have failed to respond to drug treatment or other types of drugs. It's done with the use of a tiny gadget that can transmit electrical signals to the sacral nerves in the lower spine. These devices are effective in the treatment of bladder issues. As a result of the rising prevalence of enlarged prostate, the market for sacral nerve stimulation devices is expected to expand during the forecast period.
Patients with fecal matter and bladder dysfunction can benefit from sacral nerve stimulation devices, which are both safe and effective. The market is being driven by increased demand for low invasive treatment, growing incidence of urinary bladder disorders, and technological developments including the development of newer coatings and engineering methodologies.
Key players competing in the South Africa neurology devices market are Integra LifeSciences Corporation; Smith & Nephew; Nihon Kohden Corporation; Johnson and Johnson; Abbott Laboratories; Medtronic PLC; Stryker Corporation; and Braun Melsungen AG. Some of these players are adopting several business strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares.
Some other reports from this category!